Illuminates blind spots with AI-powered analytics, so you will never miss another business incident.

Anodot illuminates business blind spots with AI analytics, so you will never miss another revenue leak or brand-damaging incident. Its automated machine learning algorithms continuously analyze all your business data and alert you in real time whenever an incident occurs, even for questions you never thought to ask. By detecting the business incidents that matter, and identifying why they happen by correlating across multiple data sources, Anodot lets you remedy urgent problems faster and capture opportunities sooner. Unlike traditional BI, Anodot has built-in data science, so any user can easily gain actionable business insights without data science expertise.

SparkBeyond has built an automated research engine, capable of asking questions and discovering complex patterns in data. The technology is designed to leverage masses of data that exist on the web, intelligently augment your data and discover complex patterns. These patterns then become powerful tools for explaining, predicting and optimizing outcomes.

Predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.

Deep Genomics is building an integrated computational system, the DG Engine, which can learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes in the context of disease. Unlike other approaches, the DG Engine accounts for the complex, interdependent layers of biological processes that are involved in disease. The technology developed at Deep Genomics is based on machine learning, a powerful and practical form of artificial intelligence. We develop new machine learning methods that can find patterns in massive datasets and infer computer models of how cells read the genome and generate biomolecules. In this way, our unique technology provides a causal interpretation for genetic variation, not just the correlative information given by industry standard techniques. We can even generate networks of known and unknown variants based on how they affect the same cellular processes, something that was not previously possible. Any variant. Any disease. Our approach opens the door to a wide range of new techniques for classifying, prioritizing, interpreting and linking genetic variants and genetically derived therapies.